You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgical Oncology
 •Breast Cancer
 •Alert me on articles by topic

Upstaging of Atypical Ductal Hyperplasia After Vacuum-Assisted 11-Gauge Stereotactic Core Needle Biopsy

David J. Winchester, MD; Joel R. Bernstein, MD; Jan M. Jeske, MD; Mary H. Nicholson, MD; Elizabeth A. Hahn, MA; Robert A. Goldschmidt, MD; William G. Watkin, MD; Stephen F. Sener, MD; Malcolm B. Bilimoria, MD; Ermilio Barrera, Jr, MD; David P. Winchester, MD

Arch Surg. 2003;138:619-623.

Background  Nonpalpable mammographic abnormalities are frequently evaluated by means of a stereotactic core needle biopsy. This technique is a very sensitive indicator of invasive cancer, but is less reliable to discriminate between ductal carcinoma in situ and atypical ductal hyperplasia (ADH). The objective of this study was to determine the correlation of the 11-gauge vacuum-assisted core needle biopsy to open biopsy when a diagnosis of ADH is obtained.

Hypothesis  The use of 11-gauge vacuum-assisted stereotactic core needle biopsy does not conclusively diagnose ADH.

Design  Retrospective analysis.

Setting  University-affiliated teaching hospital.

Patients  Mammographic findings were evaluated with an 11-gauge vacuum-assisted stereotactic core biopsy in 1750 patients. Seventy-seven patients were diagnosed as having ADH; of these, 65 underwent excisional biopsy.

Main Outcome Measures  Pathological upstaging rate.

Results  Of the 65 patients who underwent excisional breast biopsy, 11 (17%) had their condition upstaged to a breast cancer diagnosis. These patients had presented at a later age than those who retained a benign diagnosis after excisional biopsy. The number of cores taken did not correlate with diagnostic accuracy.

Conclusions  Of the 65 patients who underwent open biopsy for ADH in this series, only 83% had an accurate diagnosis. A diagnosis of ADH by stereotactic core needle biopsy should be followed by an open excisional biopsy.


From the Departments of Surgery (Drs D. J. Winchester, Sener, Bilimoria, Barrera, and D. P. Winchester), Radiology (Drs Bernstein and Jeske), Preventive Medicine (Ms Hahn), and Pathology (Drs Goldschmidt and Watkin), Evanston Northwestern Healthcare, Feinberg School of Medicine, Northwestern University, Evanston, Ill; and the Department of Radiology, Indiana University School of Medicine, Indianapolis (Dr Nicholson).


RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2003;138(6):581.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atypical Ductal Hyperplasia: Improved Accuracy with the 11-Gauge Vacuum-Assisted versus the 14-Gauge Core Biopsy Needle
Sohn et al.
Ann. Surg. Oncol. 2007;14:2497-2501.
ABSTRACT | FULL TEXT  

Underestimation of Atypical Ductal Hyperplasia at MRI-Guided 9-Gauge Vacuum-Assisted Breast Biopsy
Liberman et al.
Am. J. Roentgenol. 2007;188:684-690.
ABSTRACT | FULL TEXT  

Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
Dillon et al.
J. Clin. Pathol. 2006;59:740-743.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.